Ignite Creation Date:
2024-05-06 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05945927
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2023-06-29
Brief Title:
A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine T-DM1 as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-29
First Submit QC Date:
July 13 2023
Study First Post Date:
2023-07-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-18
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL